Antiarrhythmics---from cell to clinic: past, present, and future
Open Access
- 1 July 2000
- Vol. 84 (1) , 14-24
- https://doi.org/10.1136/heart.84.1.14
Abstract
No abstract availableThis publication has 88 references indexed in Scilit:
- Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden deathPublished by Elsevier ,2004
- The role of sarcolemmal Ca2+‐ATPase in the regulation of resting calcium concentration in rat ventricular myocytesThe Journal of Physiology, 1999
- Clinical Pharmacokinetics of MibefradilClinical Pharmacokinetics, 1998
- Heart rate reduction in the treatment of chronic stable angina pectoris: Experiences with a sinus node inhibitorAmerican Heart Journal, 1996
- The Treatment of Atrial FibrillationDrugs, 1994
- Block of single cardiac Na+ channels by antiarrhythmic drugs: The effect of amiodarone, propafenone and diprafenoneThe Journal of Membrane Biology, 1988
- Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1987
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainideCardiovascular Research, 1983
- Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channelsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1977